share_log

Karyopharm Therapeutics Says Demand for XPOVIO Was Consistent in 2024 Versus 2023 >KPTI

Karyopharm Therapeutics Says Demand for XPOVIO Was Consistent in 2024 Versus 2023 >KPTI

Karyopharm Therapeutics表示,2024年對XPOVIO的需求與2023年保持一致 >KPTI
道瓊斯 ·  01/13 13:36

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論

    聲明

    本頁的譯文內容由軟件翻譯。富途將竭力但卻不能保證翻譯內容之準確和可靠,亦不會承擔因任何不準確或遺漏而引起的任何損失或損害。